Try our Advanced Search for more refined results

Expert Analysis

CFIUS Risk Review Rules May Draw Attention To US Biotech

By Richard Matheny (September 23, 2019, 2:07 PM EDT) -- In October 2018, when the U.S. Department of the Treasury announced the new Committee on Foreign Investment in the United States pilot program addressed to critical technologies, it was first perceived by the U.S. biotech industry as a mortar round exploding in a foxhole. Scores of U.S. biotech companies strained amid the dust and rubble to understand the impact of these new rules on their ability to take foreign investment....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!